Jean-Christophe Amé

Title: Innovations of Jean-Christophe Amé

Introduction

Jean-Christophe Amé is a notable inventor based in Obernai, France. He has made significant contributions to the field of biochemistry, particularly in the study of poly(ADP-ribose) glycohydrolase (PARG) enzymes. With a total of 2 patents, his work has implications for various therapeutic applications.

Latest Patents

Amé's latest patents focus on the isolation and characterization of cDNAs encoding PARG enzymes. These enzymes play a crucial role in the cellular response to DNA damage. His inventions describe methods for inhibiting PARG expression or overexpressing it for therapeutic benefits. The implications of his work extend to the treatment of neoplastic disorders, heart attacks, strokes, and neurodegenerative diseases. Additionally, he has developed methods for detecting mutant PARG alleles and described antibodies that are immunoreactive with PARGs and their fragments.

Career Highlights

Jean-Christophe Amé is affiliated with the University of Kentucky Research Foundation. His research has contributed to a deeper understanding of the cellular mechanisms involved in DNA damage response. His innovative approaches have opened new avenues for therapeutic interventions in serious health conditions.

Collaborations

Some of his notable coworkers include Myron K Jacobson and Elaine L Jacobson. Their collaborative efforts have further advanced the research in the field of PARG enzymes.

Conclusion

Jean-Christophe Amé's work exemplifies the intersection of innovation and therapeutic application in biochemistry. His contributions continue to influence the understanding and treatment of critical health issues.